Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression

This study from Nuclear Imaging Institute is assessing an ultralow dose PET imaging technique using 18F-DCFPyL to detect prostate cancer with significantly reduced radiation exposure. Healthy volunteers and patients will be imaged for up to three hours to optimize scan timing and reconstruction.